Studying the expression of CD44 on tumour infiltrating ILC and peripheral blood confirmed high expression of CD44 on all ILC populations in patients with breast or malignant GI tumours (Fig. 4c and Additional file 1: Figure S2, Additional file 1: Figure S3, Additional file 1: Figure S4, Additional file 1: Figure S5). Here, CD44 is linked to neoplasm.